Publications

Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

Download PDF
Resource: Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

.

Related Articles

High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq

Link
Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma

Link